RNA Drug Platforms



Multi-omics platform



Nucleotide modification platform

Druggability of RNA is determined by multiple aspects, resembling the barrel theory, in which defects in any aspects may interfere RNA druggability.  NeoCura builds 4 important platforms in the early stage and applied related patents to boost RNA druggability. The platforms include RNA platform (3 different RNA types), delivery platform (LNP delivery system and new delivery system), multi-omics platform (NGS, ribo-Seq, SHAPE-seq) and nucleotide modification platform. The 4 platforms are working together and keeping a balanced development to maximize RNA overall druggability.

Scan code to follow us on WeChat

NeoCura Bio-Medical Technology Co., Ltd.

Beijing: 3/F, Building 1,20 Life Science Park Road, Life Science Park,Changping District, Beijing





Tel+86 10 80766127

Guangzhou: 10/F, Block B, No. 388 Lianyun Road, Huangpu District, Guangzhou, China

Shenzhen: 12/F, Block B, Building 1, Yinxingzhijie Phase II, Longhua District, Shenzhen, China


  • Telephone

    • 010-80766127
  • ΢ɨһɨ

seo seo